📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Preclinical development and first-in-human study of ATX-MS-1467 for immunotherapy of MS. (2015)

First Author: Streeter HB

Attributed to: Targeting GSK-3 in antigen-specific immunotherapy funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1212/nxi.0000000000000093

PubMed Identifier: 25798453

Publication URI: http://europepmc.org/abstract/MED/25798453

Type: Journal Article/Review

Volume: 2

Parent Publication: Neurology(R) neuroimmunology & neuroinflammation

Issue: 3

ISSN: 2332-7812